The law firm of Brower Piven, A Professional Corporation, is announcing an investigation into Physician’s Formula Holdings, Inc. (“Physician’s Formula” or the “Company”) (Nasdaq: FACE) and Swander Pace Capital’s (“Swander Pace”) proposed merger agreement ( “Proposed Buyout”) in which Swander Pace affiliates will acquire all outstanding shares of Physician’s Formula’s common stock at $4.25 per share (or approximately $65 million).
According to Bloomberg, as recently as August 6, 2012, one analyst had set a high price target of $5.00 per share. Moreover, the EBITDA, revenue, and total asset multiples for the Proposed Buyout are lower than the median multiples for comparable transactions.
The Proposed Buyout, subject to various closing conditions, is expected to close later this year. Upon completion, Physician’s Formula’s stockholders will cease to have any equity interest in the Company and will have no right to participate in its earnings and future growth.
If you currently own shares of Physician’s Formula and would like to learn more about the investigation, you may email or call Brower Piven, who will, without obligation or cost to you, attempt to answer your questions. You may contact Brower Piven by email at
, by calling (410) 415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and other class action cases of over 60 years.